Corvus Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Depreciation and Depletion 0.15M0.59M
Share-based Compensation 0.43M3.83M6.23M7.13M7.35M5.75M4.23M2.69M2.15M3.00M
Gains from Investment Securities 0.71M0.87M0.30M1.10M0.40M0.30M1.00M-0.97M-1.07M33.38M
Cash from Operations -11.33M-27.86M-46.21M-40.99M-37.32M-34.78M-36.72M-27.02M-23.93M-25.42M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.04M0.65M-0.20M-0.61M-0.64M0.15M0.24M0.17M0.89M1.14M
Depreciation & Amortization (CF) 0.15M0.59M0.84M0.85M0.74M0.63M0.46M0.37M0.15M0.09M
Change in Working Capital
Change in Receivables 0.51M0.08M-0.56M0.05M
Change in Account Payables 1.24M0.52M1.55M-1.46M0.45M1.02M-1.90M0.41M-0.45M1.06M
Change in Accured Expenses 1.22M2.81M1.50M-0.56M2.04M0.70M-0.52M0.47M-3.58M-0.24M
Other Working Capital Changes 1.26M0.69M-0.43M-0.19M0.77M0.88M-1.34M-1.05M-1.23M1.59M
Investing Activities
Capital Expenditures 1.75M2.20M0.27M0.35M0.03M0.08M0.01M0.27M0.03M
Sales of Property, Plant and Equipment 0.02M0.01M
Change in Acquisitions & Divestments 14.10M213.72M173.40M132.02M141.87M86.38M30.92M43.16M62.62M42.63M
Cash from Investing Activities -92.03M-42.56M84.83M-30.19M3.25M44.77M21.56M-23.28M15.54M-27.48M
Financing Activities
Other financing activities 0.73M5.03M
Cash from Financing Activities 94.95M71.36M1.44M65.27M0.02M1.31M62.16M7.86M49.03M
Additional items
Change in Cash -8.41M0.94M40.06M-5.91M-34.04M11.30M47.00M-50.30M-0.54M-3.88M
Free Cash Flow -13.07M-30.06M-46.48M-41.34M-37.35M-34.85M-36.72M-27.29M-23.97M-25.42M
Net Cash Flow -8.41M0.94M40.06M-5.91M-34.04M11.30M47.00M-50.30M-0.54M-3.88M